Robert C. Gallo Looks Beyond NIH and Defends The Past

Interview With: FRANKLIN HOKE, pp.12 Date: November 14, 1994 Gallo's Laboratory of Tumor Cell Biology in the National Cancer Institute at the National Institutes of Health developed a blood test to detect HIV antibodies and thus help ensure virus-free blood supplies worldwide. But shortly after the lab's findings were announced, information emerged that researchers in the laboratory of Luc Montagnier at the Institut Pasteur in P

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Interview With: FRANKLIN HOKE, pp.12
Date: November 14, 1994

Gallo's Laboratory of Tumor Cell Biology in the National Cancer Institute at the National Institutes of Health developed a blood test to detect HIV antibodies and thus help ensure virus-free blood supplies worldwide. But shortly after the lab's findings were announced, information emerged that researchers in the laboratory of Luc Montagnier at the Institut Pasteur in Paris had been the ones to first identify a virus they called LAV, and had, in fact, supplied Gallo's lab with early isolates -- later shown to be genetically identical to Gallo's HTLV-III virus. The revelation strongly suggested that Gallo had taken credit for a discovery that was not his. Years of United States government investigations of alleged misconduct by Gallo and his researchers in his lab ensued, as well as difficult discussions between U.S. and French officials concerning what should constitute a fair apportionment ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Franklin Hoke

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio